List of insiders holdings for Immix Biopharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Hsu Jason Director | 2024-08-26 16:45:32 | 845,300 3,965,913 | 4,811,213 | Form 4 |
Chudnovsky Yekaterina Director 10% Owner | 2024-06-21 17:45:16 | 33,000 3,241,076 | 3,274,076 | Form 4 |
Rachman Ilya M CEO and Chairman | 2024-06-21 17:45:13 | 1,476,259 0 | 1,476,259 | Form 4 |
Ng Carey Director | 2024-08-19 20:45:04 | 20,000 1,025,221 | 1,045,221 | Form 4 |
Morris Gabriel S CFO | 2024-06-21 17:45:10 | 625,834 294,985 | 920,819 | Form 4 |
Torchilin Vladimir P Scientific Co-Founder | 2021-12-20 16:15:22 | 905,200 0 | 905,200 | Form 4 |
Senn Sean Under 10% owner | 2022-07-22 16:12:46 | 899,800 0 | 899,800 | Form 4/A |
Adams Helen C. Director | 2024-06-21 17:45:10 | 207,754 0 | 207,754 | Form 4 |
Marquet Magda Director | 2024-06-21 17:45:17 | 79,092 20,000 | 99,092 | Form 4 |
BUCHAN JANE Director | 2024-06-21 17:45:11 | 55,455 0 | 55,455 | Form 4 |
Ross Graham CMO & Head of Clinical Dev. | 2021-12-15 21:01:13 | 15,000 0 | 15,000 | Form 3 |